AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

ABVC BIOPHARMA, INC. Director's Dealing 2021

Nov 5, 2021

34380_dirs_2021-11-05_c2718146-abb8-4e23-bf5e-6d0808c8e76f.zip

Director's Dealing

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: ABVC BIOPHARMA, INC. (ABVC)
CIK: 0001173313
Period of Report: 2021-08-02

Reporting Person: Doong Howard (Chief Executive Officer)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	18404	Direct